This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


The Cholinergic Deficit in Alzheimer’s Disease

Peter J. Whitehouse, M.D., Ph.D.

Published: March 1, 1998

Article Abstract

The history of the discovery of cholinergic deficit in Alzheimer’s disease is briefly reviewed, focusingon the cholinergic basal forebrain. The anatomy of the structure is discussed, and the clinicalimplications of pathology in this population of nerve cells are presented.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: Dementia , Neurologic and Neurocognitive

Sign-up to stay
up-to-date today!


Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...